The articles listed on this page are from a variety of sources. 
1. The staff of DBS-STN often attends conferences or educational opportunities both nationally and internationally, and a brief understandable write-up of the information presented at the event will be provided for our readers to review. 
2. DBS-STN staff also identifies or writes various articles related to topics that are thought to be of interest for the reader of www.DBS-STN.org. 

Browse by Topic:
Search:

Exenatide Has Potential as a Disease Modifying Agent in Parkinson`s Disease


(May 12, 2014) – Exenatide, a medication used in the treatment of insulin resistance in patients with Type 2 diabetes, has been proposed as a disease modifying drug for people living with Parkinson’s disease (PD). A follow-up study of patients with PD showed that improvements persisted twelve months after discontinuing exenatide therapy. Read more…



Article Archive

back